Updated Jul 16, 2026
Muller Lorenz is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $146K.
Lorenz Muller is the Chief Commercial Officer at Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on developing etripamil for cardiovascular treatments. He has been involved in the company's efforts to commercialize innovative therapies for patients with heart conditions.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-28 | MIST | Milestone Pharmaceuticals Inc. | S — Open-market sale | 11.2K | $1.93 | $22K |
| 2026-01-28 | MIST | Milestone Pharmaceuticals Inc. | M — Option exercise | 20.1K | — | |
| 2026-01-28 | MIST | Milestone Pharmaceuticals Inc. | S — Open-market sale | 53.6K | $2.32 | $124K |
| 2026-01-28 | MIST | Milestone Pharmaceuticals Inc. | A — Grant or award | 100.0K | — | |
| 2025-07-11 | MIST | Milestone Pharmaceuticals Inc. | A — Grant or award | 66.7K | — |
Lorenz Muller is the Chief Commercial Officer at Milestone Pharmaceuticals Inc., a biopharmaceutical company focused on developing etripamil for cardiovascular treatments. He has been involved in the company's efforts to commercialize innovative therapies for patients with heart conditions.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($146K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Muller Lorenz profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.